Kotyla P - Search Results

1

Novel Therapeutic Strategies in the Treatment of Systemic Sclerosis.

Gumkowska-Sroka O, Kotyla K, Mojs E, Palka K, Kotyla P. Gumkowska-Sroka O, et al. Among authors: kotyla p. Pharmaceuticals (Basel). 2023 Jul 27;16(8):1066. doi: 10.3390/ph16081066. Pharmaceuticals (Basel). 2023. PMID: 37630981 Free PMC article. Review.

2

[Cyclosporine: properties, mechanism of action and application in therapy of rheumatoid arthritis].

Kotyla PJ, Kucharz EJ, Sliwińska-Kotyla B. Kotyla PJ, et al. Pol Arch Med Wewn. 1998 Nov;100(5):459-64. Pol Arch Med Wewn. 1998. PMID: 10410582 Review. Polish. No abstract available.

3

[Schnitzler's syndrome].

Lewicki M, Lewicka K, Kotyla PJ, Kotulska A, Goździk J, Błach A, Banaś M, Kucharz EJ. Lewicki M, et al. Pol Arch Med Wewn. 2004 Jun;111(6):735-41. Pol Arch Med Wewn. 2004. PMID: 15508798 Review. Polish. No abstract available.

4

[Cyclooxygenases, structure, biological functions and the role in inflammation processes].

Kotyla PJ, Sliwińska-Kotyla B, Kucharz EJ. Kotyla PJ, et al. Pol Arch Med Wewn. 2001 Oct;106(4):963-6. Pol Arch Med Wewn. 2001. PMID: 11993417 Review. Polish. No abstract available.

5

[The role of Chlamydia pneumoniae infection in the development of atherosclerosis in humans].

Kotyla PJ, Sliwińska-Kotyla B, Kucharz EJ. Kotyla PJ, et al. Pol Arch Med Wewn. 2002 Dec;108(6):1239-44. Pol Arch Med Wewn. 2002. PMID: 12687938 Review. Polish. No abstract available.

6

Hypothyroidism contributes to increased triglyceride levels among patients with systemic sclerosis.

Kotyla PJ, Lewicki M, Kucharz EJ. Kotyla PJ, et al. J Rheumatol. 2006 Apr;33(4):827; author reply 627. J Rheumatol. 2006. PMID: 16583490 No abstract available.

7

Treatment with infliximab may contribute to the development of peripheral neuropathy among the patients with rheumatoid arthritis.

Kotyla PJ, Sliwinska-Kotyla B, Kucharz EJ. Kotyla PJ, et al. Clin Rheumatol. 2007 Sep;26(9):1595-6. doi: 10.1007/s10067-007-0657-3. Epub 2007 Jun 5. Clin Rheumatol. 2007. PMID: 17549580 No abstract available.

8

[Pleiotropic activity of 3-hydroxy-3-methyl-glutharyl-coenzyme a inhibitors (statins). therapeutic potential in connective tissue diseases ].

Kotyla PJ. Kotyla PJ. Ann Acad Med Stetin. 2014;60(1):39-45; discussion 45-6. Ann Acad Med Stetin. 2014. PMID: 25518091 Review. Polish.

9

Etanercept increases tumor necrosis factor-alpha level but not sFas level in patients with rheumatoid arthritis.

Kotyla P, Jankiewicz-Ziobro K, Owczarek A, Kucharz EJ. Kotyla P, et al. Isr Med Assoc J. 2015 Jan;17(1):14-8. Isr Med Assoc J. 2015. PMID: 25739170 Free article. Clinical Trial.

10

Serum lipid profile in patients with systemic sclerosis: relationship to the thyreometabolic state.

Kotyla PJ, Gozdzik J, Lewicki M, Kotulska AT, Kucharz EJ. Kotyla PJ, et al. Rheumatol Int. 2006 Apr;26(6):583-4. doi: 10.1007/s00296-005-0075-2. Epub 2005 Nov 12. Rheumatol Int. 2006. PMID: 16284768 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

74 results

Search Page

Filters